间变性大细胞淋巴瘤
医学
间变性淋巴瘤激酶
淋巴瘤
外周T细胞淋巴瘤
T细胞淋巴瘤
大细胞
病理
肿瘤科
T细胞
癌症研究
内科学
癌症
免疫学
免疫系统
腺癌
恶性胸腔积液
肺癌
作者
Francesco d’Amore,Philippe Gaulard,Lorenz Trümper,Paolo Corradini,W. S. Kim,Lena Specht,Martin Bjerregård Pedersen,Marco Ladetto
标识
DOI:10.1093/annonc/mdv201
摘要
The present guidelines cover the systemic subtypes of primary nodal and primary extranodal peripheral T-cell lymphomas (PTCLs). ESMO guidelines for primary cutaneous T-cell lymphomas are published separately [1]. Primary leukaemic PTCL subtypes (i.e. T-cell prolymphocytic leukaemia, T-cell large granular lymphocytic leukaemia, adult T-cell leukaemia/lymphoma and aggressive NK-cell leukaemia) are not covered by the present guidelines. Primary nodal PTCLs include PTCL-not otherwise specified (PTCL-NOS), anaplastic large-cell lymphoma (ALCL), both fusion protein ALCL anaplastic lymphoma kinase positive (ALCL ALK+) and ALCL anaplastic lymphoma kinase negative (ALCL ALK-), and angioimmunoblastic T-cell lymphoma (AITL).
科研通智能强力驱动
Strongly Powered by AbleSci AI